Skip to content
OpenCapital
Get started

PACS Group PACS Equity Method Investments

Equity Method Investments at other companies

Sabra Healthcare logo
Sabra HealthcareSBRA
$116.54M-3.6%
GHC
Graham HoldingsGHC
$49.4M-34.1%
American Healthcare REIT logo
American Healthcare REITAHR
$4.42M-63.4%
Healthpeak Properties logo
Healthpeak PropertiesDOC
$530.35M-44.3%
ResMed logo
ResMedRMD
——

Other financials

Income statement

See full
Revenue$1.4B+11.2%
Gross profit$346.0M+36.5%
Operating income$120.0M+149%
Net income$80.7M+183%
EPS (diluted)$0.50+194%

Balance sheet

See full
Cash & equivalents$273.7M-5.8%
Total debt$3.5B-3.2%
Total equity$1.0B+38.2%
Total assets$5.7B+3.1%

Cash flow

See full
Operating cash flow$236.3M+57.3%
CapEx$21.8M+23.2%
Free cash flow$214.5M+61.9%

Valuation

See full
Market cap$5.79B+189%

Profitability

See full
Gross margin23%+3.7pp
Operating margin7%+4.6pp
Net margin4.5%+3.4pp
FCF margin7.7%—

Returns & leverage

See full
Return on equity27.3%+15.8pp
Debt / equity3.3×-1.4×
Current ratio1×0.0×

Where this comes from

Reported directly by PACS Group in its filing.

Tagged under the XBRL concept us-gaap:EquityMethodInvestments.

The official record: PACS Group’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about PACS Group's equity method investments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is PACS Group's equity method investments?
PACS Group (PACS) reported equity method investments of $29.82M in Q1 2026.
How has PACS Group's equity method investments changed year-over-year?
PACS Group's equity method investments decreased by 16.2% year-over-year, from $35.57M to $29.82M.
What is the long-term trend for PACS Group's equity method investments?
Over 2 years (2023 to 2025), PACS Group's equity method investments has grown at a 57.8% compound annual growth rate (CAGR), from $12.36M to $30.8M.
What does equity method investments mean?
Investments in unconsolidated affiliates and joint ventures where the company has significant influence (typically 20-50% ownership), carried at proportional book value.